Visualization of mycobacterial membrane dynamics in live cells

Mycobacteria are endowed with a highly impermeable mycomembrane that confers intrinsic resistance to many antibiotics. Several unique mycomembrane glycolipids have been isolated and structurally characterized, but the underlying organization and dynamics of glycolipids within the cell envelope remain poorly understood. We report here a study of mycomembrane dynamics that was enabled by trehalose–fluorophore conjugates capable of labeling trehalose glycolipids in live actinomycetes. We identified fluorescein–trehalose analogues that are metabolically incorporated into the trehalose mycolates of representative Mycobacterium, Corynebacterium, Nocardia, and Rhodococcus species. Using these probes, we studied the mobilities of labeled glycolipids by time-lapse microscopy and fluorescence recovery after photobleaching experiments and found that mycomembrane fluidity varies widely across species and correlates with mycolic acid structure. Finally, we discovered that treatment of mycobacteria with ethambutol, a front-line tuberculosis (TB) drug, significantly increases mycomembrane fluidity. These findings enhance our understanding of mycobacterial cell envelope structure and dynamics and have implications for development of TB drug cocktails.

[1]  K. Tamvakis.  Molécules , 2020, Merveilleuses structures.

[2]  Nitsan Chorev.  1. The World Health Organization , 2017 .

[3]  C. Thompson,et al.  Repurposing clinically approved cephalosporins for tuberculosis therapy , 2016, Scientific Reports.

[4]  A. Baulard,et al.  Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria , 2016, Antimicrobial Agents and Chemotherapy.

[5]  Mingliang Zhou,et al.  Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability , 2016, Scientific Reports.

[6]  Benjamin M. Swarts,et al.  Bioorthogonal Chemical Reporters for Selective In Situ Probing of Mycomembrane Components in Mycobacteria. , 2016, Angewandte Chemie.

[7]  G. Besra,et al.  Assembly of the Mycobacterial Cell Wall. , 2015, Annual review of microbiology.

[8]  E. Brown,et al.  Unconventional screening approaches for antibiotic discovery , 2015, Annals of the New York Academy of Sciences.

[9]  C. Bertozzi,et al.  Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface. , 2015, FEMS microbiology reviews.

[10]  R. Kalscheuer,et al.  Chemoenzymatic Synthesis of Trehalose Analogues: Rapid Access to Chemical Probes for Investigating Mycobacteria , 2014, Chembiochem : a European journal of chemical biology.

[11]  C. Bertozzi,et al.  Subpolar addition of new cell wall is directed by DivIVA in mycobacteria , 2014, Proceedings of the National Academy of Sciences.

[12]  D. Ronning,et al.  Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors* , 2014, The Journal of Biological Chemistry.

[13]  D. Zerbib,et al.  Mycobacterium tuberculosis Proteins Involved in Mycolic Acid Synthesis and Transport Localize Dynamically to the Old Growing Pole and Septum , 2014, PloS one.

[14]  M. Daffé,et al.  Mycolic acids: structures, biosynthesis, and beyond. , 2014, Chemistry & biology.

[15]  D. Ronning,et al.  Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen , 2013, Nature Communications.

[16]  Alimuddin Zumla,et al.  Advances in the development of new tuberculosis drugs and treatment regimens , 2013, Nature Reviews Drug Discovery.

[17]  Pamela J. B. Brown,et al.  In Situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids. , 2012, Angewandte Chemie.

[18]  C. Bertozzi,et al.  Probing the Mycobacterial Trehalome with Bioorthogonal Chemistry , 2012, Journal of the American Chemical Society.

[19]  Xiaoyuan Wang,et al.  Purification and structure analysis of mycolic acids in Corynebacterium glutamicum , 2012, The Journal of Microbiology.

[20]  G. Drummen,et al.  Advanced Fluorescence Microscopy Techniques—FRAP, FLIP, FLAP, FRET and FLIM , 2012, Molecules.

[21]  J. Ernst,et al.  Tuberculosis pathogenesis and immunity. , 2012, Annual review of pathology.

[22]  Santiago Ramón-García,et al.  Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen , 2011, Antimicrobial Agents and Chemotherapy.

[23]  B. G. Davis,et al.  Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis. , 2011, Nature chemical biology.

[24]  W. Bishai,et al.  Alterations in Phospholipid Catabolism in Mycobacterium Tuberculosis LysX Mutant , 2011, Front. Microbio..

[25]  M. Glickman,et al.  Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. , 2009, Chemistry & biology.

[26]  Mohamed Chami,et al.  Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State , 2008, Journal of bacteriology.

[27]  Andrew Leis,et al.  Disclosure of the mycobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal the lipid bilayer structure , 2008, Proceedings of the National Academy of Sciences.

[28]  E. Rubin,et al.  Bacterial Growth and Cell Division: a Mycobacterial Perspective , 2008, Microbiology and Molecular Biology Reviews.

[29]  刘金明,et al.  IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A , 2005 .

[30]  K. Young,et al.  Helical Disposition of Proteins and Lipopolysaccharide in the Outer Membrane of Escherichia coli , 2005, Journal of bacteriology.

[31]  H. Nikaido,et al.  Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis , 2004, Antimicrobial Agents and Chemotherapy.

[32]  M. Pallen,et al.  Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae. , 2004, FEMS microbiology reviews.

[33]  David G. Russell,et al.  Mycobacterium tuberculosis: here today, and here tomorrow , 2001, Nature Reviews Molecular Cell Biology.

[34]  H. David,et al.  Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors. , 2000, The Journal of antimicrobial chemotherapy.

[35]  I. Yano,et al.  Mycolic acids from Rhodococcus, Gordonia, and Dietzia. , 2000, Journal of microbiological methods.

[36]  I. Yano,et al.  Mycolic acid analysis in Nocardia species. The mycolic acid compositions of Nocardia asteroides, N. farcinica, and N. nova. , 1999, Journal of microbiological methods.

[37]  M R Barer,et al.  Lipid domains of mycobacteria studied with fluorescent molecular probes , 1999, Molecular microbiology.

[38]  S. Hoffner,et al.  Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime. , 1997, Diagnostic microbiology and infectious disease.

[39]  A. Telenti,et al.  The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol , 1997, Nature Medicine.

[40]  J. Musser,et al.  MMAS-1, the Branch Point Between cis- and trans-Cyclopropane-containing Oxygenated Mycolates in Mycobacterium tuberculosis* , 1997, The Journal of Biological Chemistry.

[41]  J. Liu,et al.  Mycolic Acid Structure Determines the Fluidity of the Mycobacterial Cell Wall* , 1996, The Journal of Biological Chemistry.

[42]  H. Nikaido,et al.  Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Sherman,et al.  The Biosynthesis of Cyclopropanated Mycolic Acids in Mycobacterium tuberculosis , 1995, The Journal of Biological Chemistry.

[44]  G. Besra,et al.  Biogenesis of the mycobacterial cell wall and the site of action of ethambutol , 1995, Antimicrobial agents and chemotherapy.

[45]  H. Nikaido,et al.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics. , 1994, FEMS microbiology letters.

[46]  Sung-Hou Kim,et al.  Physical organization of lipids in the cell wall of Mycobacterium chelonae , 1993, Molecular microbiology.

[47]  K. Kaneda,et al.  Molecular species of mycolic acid subclasses in eight strains ofMycobacterium smegmatis , 1988, Lipids.

[48]  K. Takayama,et al.  Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis , 1981, Antimicrobial Agents and Chemotherapy.

[49]  D. Koppel,et al.  Lateral diffusion of lipopolysaccharide in the outer membrane of Salmonella typhimurium , 1980, Nature.

[50]  E. L. Armstrong,et al.  Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis , 1979, Antimicrobial Agents and Chemotherapy.

[51]  V. Speth,et al.  Outer membrane of salmonella. Sites of export of newly synthesised lipopolysaccharide on the bacterial surface. , 1973, European journal of biochemistry.

[52]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[53]  Ying Zhang,et al.  The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.

[54]  H. Nikaido,et al.  The envelope of mycobacteria. , 1995, Annual review of biochemistry.

[55]  R. Williams,et al.  Journal of American Chemical Society , 1979 .